{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:13:03Z","timestamp":1771632783718,"version":"3.50.1"},"reference-count":108,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014364","name":"National Children's Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The interleukin (IL)-36 family is a member of the IL-1 superfamily of cytokines and, in common with other IL-1 family members, has been shown to exhibit pleiotropic effects in homeostasis and inflammation. Although the important role these cytokines play in the skin has been widely reported, recent evidence suggests that IL-36 family members are expressed and can also exert significant influence at the intestinal mucosa. In this review, we summarize current knowledge surrounding the role of the IL-36 in the intestines. In particular, we examine its likely dichotomous role as a mediator of both inflammation and resolution, highlighting its overlapping roles in innate and adaptive inflammation at the mucosa and its contribution to pathophysiology of inflammatory bowel disease. We also summarize the complexities of targeting this cytokine family in a clinical setting.<\/jats:p>","DOI":"10.1093\/ibd\/izaa232","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T17:06:20Z","timestamp":1598893580000},"page":"440-450","source":"Crossref","is-referenced-by-count":21,"title":["The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution"],"prefix":"10.1093","volume":"27","author":[{"given":"Gemma","family":"Leon","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, School of Medicine, Trinity College Dublin , Dublin, Ireland"},{"name":"National Children\u2019s Research Centre, Our Lady\u2019s Children\u2019s Hospital , Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seamus","family":"Hussey","sequence":"additional","affiliation":[{"name":"National Children\u2019s Research Centre, Our Lady\u2019s Children\u2019s Hospital , Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0130-8766","authenticated-orcid":false,"given":"Patrick T","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, School of Medicine, Trinity College Dublin , Dublin, Ireland"},{"name":"National Children\u2019s Research Centre, Our Lady\u2019s Children\u2019s Hospital , Crumlin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"2022092610002221000_CIT0001","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity."},{"key":"2022092610002221000_CIT0002","volume-title":"National Centre for Biotechnology Information - Gene Database.","year":"2020"},{"key":"2022092610002221000_CIT0003","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/eji.201848056","article-title":"Current perspectives on the interleukin-1 family as targets for inflammatory disease","volume":"49","author":"Hernandez-Santana","year":"2019","journal-title":"Eur J Immunol."},{"key":"2022092610002221000_CIT0004","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3389\/fimmu.2019.01091","article-title":"IL-33 and IL-18 in inflammatory bowel disease etiology and microbial interactions","volume":"10","author":"Williams","year":"2019","journal-title":"Front Immunol."},{"key":"2022092610002221000_CIT0005","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet."},{"key":"2022092610002221000_CIT0006","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2017.05.003","article-title":"Epidemiology, natural history, and risk stratification of Crohn\u2019s disease","volume":"46","author":"Aniwan","year":"2017","journal-title":"Gastroenterol Clin North Am."},{"key":"2022092610002221000_CIT0007","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med."},{"key":"2022092610002221000_CIT0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fped.2017.00141","article-title":"Crohn\u2019s strictures-moving away from the knife","volume":"5","author":"Stenke","year":"2017","journal-title":"Front Pediatr."},{"key":"2022092610002221000_CIT0009","doi-asserted-by":"crossref","first-page":"928461","DOI":"10.1155\/2014\/928461","article-title":"Role of Th17 cells in the pathogenesis of human IBD","volume":"2014","author":"G\u00e1lvez","year":"2014","journal-title":"ISRN Inflamm."},{"key":"2022092610002221000_CIT0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn\u2019s disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin Exp Immunol."},{"key":"2022092610002221000_CIT0011","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13317-013-0049-4","article-title":"Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis","volume":"4","author":"Vounotrypidis","year":"2013","journal-title":"Auto Immun Highlights."},{"key":"2022092610002221000_CIT0012","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/gut.30.6.835","article-title":"Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn\u2019s disease","volume":"30","author":"Mahida","year":"1989","journal-title":"Gut."},{"key":"2022092610002221000_CIT0013","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/gut.42.2.214","article-title":"Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease","volume":"42","author":"McAlindon","year":"1998","journal-title":"Gut."},{"key":"2022092610002221000_CIT0014","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF01540912","article-title":"Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn\u2019s disease","volume":"16","author":"Reimund","year":"1996","journal-title":"J Clin Immunol."},{"key":"2022092610002221000_CIT0015","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3389\/fimmu.2018.02764","article-title":"Dynamics of colon monocyte and macrophage activation during colitis","volume":"9","author":"Jones","year":"2018","journal-title":"Front Immunol."},{"key":"2022092610002221000_CIT0016","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2018.06.029","article-title":"Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1\u03b2 and IL-18","volume":"155","author":"Impellizzeri","year":"2018","journal-title":"Biochem Pharmacol."},{"key":"2022092610002221000_CIT0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature."},{"key":"2022092610002221000_CIT0018","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N Engl J Med."},{"key":"2022092610002221000_CIT0019","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2249.2004.02431.x","article-title":"Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes","volume":"136","author":"Okazawa","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"2022092610002221000_CIT0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/bbrc.1997.6665","article-title":"Interleukin-18 activates NF-kappaB in murine T helper type 1 cells","volume":"234","author":"Matsumoto","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"key":"2022092610002221000_CIT0021","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.181.3.1627","article-title":"Cutting edge: priming of NK cells by IL-18","volume":"181","author":"Chaix","year":"2008","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0022","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity."},{"key":"2022092610002221000_CIT0023","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cell.2014.01.026","article-title":"NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion","volume":"156","author":"Wlodarska","year":"2014","journal-title":"Cell."},{"key":"2022092610002221000_CIT0024","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell."},{"key":"2022092610002221000_CIT0025","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/mi.2015.13","article-title":"Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine","volume":"8","author":"Harrison","year":"2015","journal-title":"Mucosal Immunol."},{"key":"2022092610002221000_CIT0026","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","article-title":"Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells","volume":"167","author":"Sugawara","year":"2001","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0027","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.162.11.6829","article-title":"IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn\u2019s disease: expression and localization in intestinal mucosal cells","volume":"162","author":"Pizarro","year":"1999","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0028","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","article-title":"Epithelial IL-18 equilibrium controls barrier function in colitis","volume":"163","author":"Nowarski","year":"2015","journal-title":"Cell."},{"key":"2022092610002221000_CIT0029","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet."},{"key":"2022092610002221000_CIT0030","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.4049\/jimmunol.1302727","article-title":"The IL18RAP region disease polymorphism decreases IL-18RAP\/IL-18R1\/IL-1R1 expression and signaling through innate receptor-initiated pathways","volume":"192","author":"Hedl","year":"2014","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0031","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"2022092610002221000_CIT0032","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"J Gastroenterol."},{"key":"2022092610002221000_CIT0033","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00535-014-0982-7","article-title":"IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis","volume":"50","author":"Seidelin","year":"2015","journal-title":"J Gastroenterol."},{"key":"2022092610002221000_CIT0034","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.3748\/wjg.v18.i41.5848","article-title":"Changes of the cytokine profile in inflammatory bowel diseases","volume":"18","author":"M\u0171zes","year":"2012","journal-title":"World J Gastroenterol."},{"key":"2022092610002221000_CIT0035","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut."},{"key":"2022092610002221000_CIT0036","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1172\/JCI88625","article-title":"IL-33 regulates the IgA-microbiota axis to restrain IL-1\u03b1-dependent colitis and tumorigenesis","volume":"126","author":"Malik","year":"2016","journal-title":"J Clin Invest."},{"key":"2022092610002221000_CIT0037","doi-asserted-by":"crossref","first-page":"27704","DOI":"10.18632\/oncotarget.15984","article-title":"IL-33-induced alternatively activated macrophage attenuates the development of TNBS-induced colitis","volume":"8","author":"Tu","year":"2017","journal-title":"Oncotarget."},{"key":"2022092610002221000_CIT0038","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2119\/molmed.2011.00428","article-title":"Interleukin-33 ameliorates experimental colitis through promoting Th2\/Foxp3+ regulatory T-cell responses in mice","volume":"18","author":"Duan","year":"2012","journal-title":"Mol Med."},{"key":"2022092610002221000_CIT0039","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imm.12111","article-title":"Interleukin-33 exacerbates acute colitis via interleukin-4 in mice","volume":"140","author":"Pushparaj","year":"2013","journal-title":"Immunology."},{"key":"2022092610002221000_CIT0041","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.intimp.2017.02.006","article-title":"IL-33 induces both regulatory B cells and regulatory T cells in dextran sulfate sodium-induced colitis","volume":"46","author":"Zhu","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"2022092610002221000_CIT0042","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1073\/pnas.0912678107","article-title":"Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis","volume":"107","author":"Pastorelli","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0043","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/ibd.22900","article-title":"IL-33 attenuates development and perpetuation of chronic intestinal inflammation","volume":"18","author":"Gro\u03b2","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2022092610002221000_CIT0044","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cyto.2015.04.009","article-title":"Interleukin 35 (IL-35) and IL-37: intestinal and peripheral expression by T and B regulatory cells in patients with inflammatory bowel disease","volume":"75","author":"Fonseca-Camarillo","year":"2015","journal-title":"Cytokine."},{"key":"2022092610002221000_CIT0045","doi-asserted-by":"crossref","first-page":"136329","DOI":"10.1155\/2014\/136329","article-title":"The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm."},{"key":"2022092610002221000_CIT0046","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/MPG.0000000000000387","article-title":"Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease","volume":"59","author":"Weidlich","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2022092610002221000_CIT0047","doi-asserted-by":"crossref","first-page":"16711","DOI":"10.1073\/pnas.1111982108","article-title":"Interleukin 37 expression protects mice from colitis","volume":"108","author":"McNamee","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0048","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1471-4906(01)02040-3","article-title":"A new nomenclature for IL-1-family genes","volume":"22","author":"Sims","year":"2001","journal-title":"Trends Immunol."},{"key":"2022092610002221000_CIT0049","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.1999.1440","article-title":"IL1HY1: a novel interleukin-1 receptor antagonist gene","volume":"263","author":"Mulero","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"key":"2022092610002221000_CIT0050","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1073\/pnas.90.16.7676","article-title":"Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes","volume":"90","author":"Kapur","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0051","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36\u03b1, IL-36\u03b2, and IL-36\u03b3) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J Biol Chem."},{"key":"2022092610002221000_CIT0052","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","article-title":"Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines","volume":"14","author":"Henry","year":"2016","journal-title":"Cell Rep."},{"key":"2022092610002221000_CIT0053","doi-asserted-by":"crossref","first-page":"24880","DOI":"10.1038\/srep24880","article-title":"Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist","volume":"6","author":"Macleod","year":"2016","journal-title":"Sci Rep."},{"key":"2022092610002221000_CIT0054","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/geno.2002.6752","article-title":"Genomic organization of the interleukin-1 locus","volume":"79","author":"Taylor","year":"2002","journal-title":"Genomics."},{"key":"2022092610002221000_CIT0055","first-page":"179","article-title":"Evaluating serum levels of IL-33, IL-36, IL-37 and gene expression of IL-37 in patients with psoriasis vulgaris","volume":"17","author":"Sehat","year":"2018","journal-title":"Iran J Allergy Asthma Immunol."},{"key":"2022092610002221000_CIT0056","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36\u03b1 is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"2022092610002221000_CIT0057","doi-asserted-by":"crossref","first-page":":eaan2585","DOI":"10.1126\/scitranslmed.aan2585","article-title":"TGF-\u03b2 type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis","volume":"11","author":"Li","year":"2019","journal-title":"Sci Transl Med."},{"key":"2022092610002221000_CIT0058","doi-asserted-by":"crossref","first-page":"19588","DOI":"10.3390\/molecules201019588","article-title":"Elevated expression and pro-inflammatory activity of IL-36 in patients with systemic lupus erythematosus","volume":"20","author":"Chu","year":"2015","journal-title":"Molecules."},{"key":"2022092610002221000_CIT0059","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mi.2015.134","article-title":"IL-36\u03b1 expression is elevated in ulcerative colitis and promotes colonic inflammation","volume":"9","author":"Russell","year":"2016","journal-title":"Mucosal Immunol."},{"key":"2022092610002221000_CIT0060","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mi.2017.21","article-title":"IL-36\u03b3 signaling controls the induced regulatory T cell-Th9 cell balance via NF\u03baB activation and STAT transcription factors","volume":"10","author":"Harusato","year":"2017","journal-title":"Mucosal Immunol."},{"key":"2022092610002221000_CIT0061","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2015-310374","article-title":"IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo","volume":"66","author":"Scheibe","year":"2017","journal-title":"Gut."},{"key":"2022092610002221000_CIT0062","doi-asserted-by":"crossref","first-page":"5140691","DOI":"10.1155\/2018\/5140691","article-title":"Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease","volume":"2018","author":"Fonseca-Camarillo","year":"2018","journal-title":"Biomed Res Int."},{"key":"2022092610002221000_CIT0063","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41467-019-11944-w","article-title":"Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction","volume":"10","author":"Giannoudaki","year":"2019","journal-title":"Nat Commun."},{"key":"2022092610002221000_CIT0064","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.1501312","article-title":"Cutting edge: IL-36 receptor promotes resolution of intestinal damage","volume":"196","author":"Medina-Contreras","year":"2016","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0065","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0066","first-page":"3178","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"17","author":"Siegmund","year":"2011","journal-title":"World J Gastroenterol."},{"key":"2022092610002221000_CIT0067","doi-asserted-by":"crossref","first-page":"E5076","DOI":"10.1073\/pnas.1718902115","article-title":"A cytokine network involving IL-36\u03b3, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage","volume":"115","author":"Ngo","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0068","doi-asserted-by":"crossref","first-page":":e201900586","DOI":"10.26508\/lsa.201900586","article-title":"Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice","volume":"3","author":"Hern\u00e1ndez-Santana","year":"2020","journal-title":"Life Sci Alliance."},{"key":"2022092610002221000_CIT0069","doi-asserted-by":"crossref","first-page":":e202000688","DOI":"10.26508\/lsa.202000688","article-title":"IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis","volume":"3","author":"Goldstein","year":"2020","journal-title":"Life Sci Alliance."},{"key":"2022092610002221000_CIT0070","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3389\/fimmu.2019.01803","article-title":"IL-36\u03b2 promotes CD8+ T cell activation and antitumor immune responses by activating mTORC1","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Immunol."},{"key":"2022092610002221000_CIT0071","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"Vigne","year":"2012","journal-title":"Blood."},{"key":"2022092610002221000_CIT0072","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","article-title":"Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation","volume":"156","author":"Scheibe","year":"2019","journal-title":"Gastroenterology."},{"key":"2022092610002221000_CIT0073","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0074","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"2022092610002221000_CIT0075","doi-asserted-by":"crossref","first-page":"154963","DOI":"10.1016\/j.cyto.2019.154963","article-title":"Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation","volume":"127","author":"Xie","year":"2020","journal-title":"Cytokine."},{"key":"2022092610002221000_CIT0076","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology."},{"key":"2022092610002221000_CIT0077","doi-asserted-by":"crossref","first-page":"G786","DOI":"10.1152\/ajpgi.00059.2012","article-title":"Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease","volume":"303","author":"Rieder","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"2022092610002221000_CIT0078","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat Protoc."},{"key":"2022092610002221000_CIT0079","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/gut.2006.116467","article-title":"Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease","volume":"56","author":"Kugathasan","year":"2007","journal-title":"Gut."},{"key":"2022092610002221000_CIT0080","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.4049\/jimmunol.178.9.5859","article-title":"Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis","volume":"178","author":"Fichtner-Feigl","year":"2007","journal-title":"J Immunol."},{"key":"2022092610002221000_CIT0081","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax4783","article-title":"Interleukin-36\u03b3-producing macrophages drive IL-17-mediated fibrosis","volume":"4","author":"Sommerfeld","year":"2019","journal-title":"Sci Immunol."},{"key":"2022092610002221000_CIT0082","doi-asserted-by":"crossref","first-page":"15683","DOI":"10.1038\/s41598-019-51878-3","article-title":"The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis","volume":"9","author":"Earley","year":"2019","journal-title":"Sci Rep."},{"key":"2022092610002221000_CIT0083","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature."},{"key":"2022092610002221000_CIT0084","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1073\/pnas.0510847103","article-title":"Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury","volume":"103","author":"Berger","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2022092610002221000_CIT0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41564-019-0640-1","article-title":"Commensal Bacteroidetes protect against Klebsiella pneumoniae colonization and transmission through IL-36 signalling","volume":"5","author":"Sequeira","year":"2020","journal-title":"Nat Microbiol."},{"key":"2022092610002221000_CIT0086","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/00365521.2011.560678","article-title":"Klebsiella pneumoniae increases the risk of inflammation and colitis in a murine model of intestinal bowel disease","volume":"46","author":"Lee","year":"2011","journal-title":"Scand J Gastroenterol."},{"key":"2022092610002221000_CIT0087","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/rheumatology\/37.5.525","article-title":"Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis","volume":"37","author":"Tiwana","year":"1998","journal-title":"Br J Rheumatol."},{"key":"2022092610002221000_CIT0088","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/13543784.2016.1126247","article-title":"Anti-TNF-\u03b1 therapies for the treatment of Crohn\u2019s disease: the past, present and future","volume":"25","author":"Berns","year":"2016","journal-title":"Expert Opin Investig Drugs."},{"key":"2022092610002221000_CIT0089","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/14712590903048909","article-title":"Overview of biologic therapy for Crohn\u2019s disease","volume":"9","author":"Dryden","year":"2009","journal-title":"Expert Opin Biol Ther."},{"key":"2022092610002221000_CIT0090","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2022092610002221000_CIT0091","first-page":"243","article-title":"Advances in the development of new biologics in inflammatory bowel disease","volume":"29","author":"Ungar","year":"2016","journal-title":"Ann Gastroenterol."},{"key":"2022092610002221000_CIT0092","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jgh3.12065","article-title":"A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases","volume":"2","author":"Shim","year":"2018","journal-title":"JGH Open."},{"key":"2022092610002221000_CIT0093","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med."},{"key":"2022092610002221000_CIT0094","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.crohns.2014.06.005","article-title":"Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn\u2019s disease\u2013the McGill experience","volume":"8","author":"Kopylov","year":"2014","journal-title":"J Crohns Colitis."},{"key":"2022092610002221000_CIT0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1811317","article-title":"Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis","volume":"380","author":"Bachelez","year":"2019","journal-title":"N Engl J Med."},{"key":"2022092610002221000_CIT0096","volume-title":"NCT03752970: A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn\u2019s Disease.","author":"Ingelheim","year":"2018"},{"key":"2022092610002221000_CIT0097","volume-title":"NCT03482635: BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis","author":"Ingelheim","year":"2018"},{"key":"2022092610002221000_CIT0098","volume-title":"NCT03123120: A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy","author":"Ingelheim","year":"2017"},{"key":"2022092610002221000_CIT0099","volume-title":"NCT03648541: BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis","author":"Ingelheim","year":"2018"},{"key":"2022092610002221000_CIT0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41419-018-0385-4","article-title":"Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases","volume":"9","author":"Sullivan","year":"2018","journal-title":"Cell Death Dis."},{"key":"2022092610002221000_CIT0101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2000.009001001.x","article-title":"Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop","volume":"9","author":"Terui","year":"2000","journal-title":"Exp Dermatol."},{"key":"2022092610002221000_CIT0102","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/1523-1747.ep12616644","article-title":"Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis","volume":"99","author":"Wiedow","year":"1992","journal-title":"J Invest Dermatol."},{"key":"2022092610002221000_CIT0103","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI115994","article-title":"Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor","volume":"90","author":"McElvaney","year":"1992","journal-title":"J Clin Invest."},{"key":"2022092610002221000_CIT0104","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2009.00448.x","article-title":"Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery","volume":"158","author":"Greene","year":"2009","journal-title":"Br J Pharmacol."},{"key":"2022092610002221000_CIT0105","doi-asserted-by":"crossref","first-page":"13295","DOI":"10.1038\/s41598-019-49840-4","article-title":"Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease","volume":"9","author":"Anderson","year":"2019","journal-title":"Sci Rep."},{"key":"2022092610002221000_CIT0106","doi-asserted-by":"crossref","first-page":"G234","DOI":"10.1152\/ajpgi.00393.2015","article-title":"Pathophysiological roles of proteases in gastrointestinal disease","volume":"310","author":"Edgington-Mitchell","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"2022092610002221000_CIT0107","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41590-019-0467-1","article-title":"IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease","volume":"20","author":"H\u00f8jen","year":"2019","journal-title":"Nat Immunol."},{"key":"2022092610002221000_CIT0108","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1038\/s41598-019-45626-w","article-title":"Small molecule IL-36\u03b3 antagonist as a novel therapeutic approach for plaque psoriasis","volume":"9","author":"Todorovi\u0107","year":"2019","journal-title":"Sci Rep."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/3\/440\/46044268\/izaa232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/3\/440\/46044268\/izaa232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:51:07Z","timestamp":1696607467000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/27\/3\/440\/5898808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":108,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,29]]},"published-print":{"date-parts":[[2021,2,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa232","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,8,29]]}}}